Gommans, W.M., Tatalias, N.E., Sie, C., Dupuis, D.E., Vendetti, N.J., Smith, L., Kaushal, R., and Maas, S., 2008: Screening of human SNP database identifies recoding sites of A-to-I RNA editing. RNA, 14 (10) in press PDF
Orlowski, R.J., O'Rourke, K.S., Olorenshaw, I., Hawkins, G.A., Maas, S., and Laxminarayana, D., 2008: Altered Editing in Cyclic Nucleotide Phosphodiesterase 8A1 (PDE8A1) Gene Transcripts of Systemic Lupus Erythematosus (SLE) T Lymphocytes. Immunology, in press PDF
Wynne, R.D., Maas, S., and Saldanha, C.J., 2008: Molecular characterization of the injury-induced aromatase transcript in the adult zebra finch brain. J Neurochem., 105: 1613-1624 PDF
Gommans, W.M., Dupuis, D.E., McCane, J.E., Tatalias, N.E., and Maas, S., 2008: Diversifying Exon Code through A-to-I RNA Editing. In: DNA and RNA Editing: Mechanisms and Functions; Wiley publishers; edited by: Harold Smith, pp3-30 PDF
Laxminarayana, D., O'Rourke, K.S., Maas, S., and Olorenshaw, I., 2007: Altered Editing in RNA editing Adenosine Deaminase ADAR2 Gene Transcripts of Systemic Lupus Erythematosus (SLE) T Lymphocytes. Immunology, 121(3):359-69 PDF
Maas, S., Kawahara, Y., Tamburro, K.M., and Nishikura, K. 2006: A-to-I RNA editing and human disease. RNA Biology, 3(1) e1-9. PDF
Listen to the abstract !
Koeris, M., Funke, L., Shrestha, J., Rich. A., and Maas , S. 2005: Modulation of ADAR1 editing activity by Z-RNA in vitro. Nucleic Acids Res., 33 (16): 5362-70. PDF
Athanasiadis, A., D. Placido, S. Maas, B.A. Brown, 2nd, K. Lowenhaupt, and A. Rich , 2005: The crystal structure of the Zbeta domain of the RNA-editing enzyme ADAR1 reveals distinct conserved surfaces among Z-domains . J Mol Biol , 351 (3): 496-507. PDF
Athanasiadis, A., Rich, A., and Maas, S. 2004: Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biology, 2 (12) e391 PDF
===> Database of edited Alu containing human mRNAs: Table S1
Luciano, D.J., Mirsky, H., Vendetti, N.J., and Maas, S., 2004: RNA editing of a miRNA precursor. RNA,10(8):1174-1177 PDF
Tsibris, J.C.M., Maas, S., Segars, J.H., Nicosia, S.V., Enkemann, S.A., O'Brien, W.F., and Spellacy, W.N. 2003: New potential regulators of uterine leiomyomata from DNA arrays: The ionotropic glutamate receptor GluR2. Biochem Biophys Res Commun, 312, 249-254 PDF
Maas, S., Rich, A., and Nishikura, K., 2003: A-to-I RNA editing: recent news and remaining mysteries. J.Biol.Chem. 278 (3) 1391-4 PDF
Maas, S., Patt, S., Schrey, M., and Rich, A., 2001: Underediting of GluR-B mRNA in malignant gliomas. Proc. Natl. Acad. Sci. 98 (25), 14687-14692 PDF (see also: Editor's choice in Science Dec. 14, 2001 and in MIT TechTalk http://web.mit.edu/newsoffice/nr/2001/rna.html)
Kim, Y.G., and Maas, S., 2001: Efficient multiple site mutagenesis in vitro. In: Methods in Molecular Biology, vol. 182: In Vitro Mutagenesis, 2nd ed., pp 29-36
Maas, S., Kim, Y.G., and Rich, A. 2001: Genomic clustering of tRNAAla-specific adenosine deaminase ADAT1 and two tRNA-synthetases within a susceptibility locus for autoimmune diseases. Mamm Genome 12 (5), 387-393 PDF
Kim, Y.G., Maas, S., and Rich, A. 2001: Comparative mutational analysis of cis-acting RNA signals for translational frameshifting in HIV-1 and HTLV-2. Nucleic Acids Res. 29 (5), 1125-1131 PDF
Higuchi, M., Maas, S., Single, F.N., Hartner, J., Rozov, A., Burnashev, N., Feldmeyer, D., Sprengel, R., and Seeburg. P.H., 2000: Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406, 78-81 PDF
Kim, Y.-G., Lowenhaupt, K., Maas, S., Herbert, A., Schwartz, T., and Rich, A. 2000: The Z-DNA binding domain of ADAR1 induces formation of Z-DNA in a B-DNA environment. J.Biol.Chem. 275, 26828-26833 PDF
Maas, S., and Rich, A. 2000: Changing genetic information through RNA editing. BioEssays 22, 790-802 PDF
Kim, Y.G., Maas, S., Wang, S., and Rich, A. 2000: Mutational study reveals that tertiary interactions are conserved in ribosomal frameshifting pseudoknots of two luteoviruses. RNA 6, 1157-1165 PDF
Maas, S., Kim, Y.G., and Rich, A. 2000: Sequence, genomic organization and functional expression of the murine tRNA-specific adenosine deaminase ADAT1. Gene 243, 59-66 PDF
Kim, Y.G., and Maas, S., 2000: Efficient multiple site mutagenesis with high targeting efficiency in one cloning step. BioTechniques 28, 196-198
Maas, S., Gerber, A.P., and Rich, A. 1999: Identification and characterization of a human tRNA-specific adenosine deaminase related to the ADAR family of pre-mRNA editing enzymes. Proc. Natl. Acad. Sci. 96, 8895-8900 PDF
Maas, S., 1999: Efficient and rapid procedure for blue-white screening of recombinant bacterial clones. BioTechniques 27, 1126-1128
Kim, Y.G., Su, L., Maas, S., O'Neill, A., and Rich, A. 1999: Specific mutations in a viral RNA pseudoknot drastically change ribosomal frameshifting efficiency. Proc. Natl. Acad. Sci. 96 (25), 14234-14239 PDF
Maas, S., Melcher, T., and Seeburg, P.H. 1997: Mammalian RNA-dependent deaminases and edited mRNAs. Curr. Opin. Cell Biol. 9, 343-349 Abstract
Melcher, T.*, Maas, S.*, Herb, A., Sprengel, R., Seeburg, P.H., and Higuchi, M. 1996: A mammalian RNA editing enzyme. Nature 379, 460-464 Abstract
* equally contributing first authors
Melcher, T., Maas, S., Herb, A., Sprengel, R., Higuchi, M., and Seeburg, P.H. 1996: Red2, a brain specific member of the RNA-specific adenosine deaminase family. J.Biol.Chem. 271, 31795-31798 PDF
Maas, S., Melcher, T., Herb, A., Seeburg, P.H., Keller, W., Krause, S., Higuchi, M., and O'Connell, M. 1996: Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase. J.Biol.Chem. 271, 12221-12226 PDF
Melcher, T., Maas, S., Higuchi, M., Keller, W., and Seeburg, P.H. 1995: Editing of AMPA receptor GluR-B pre-mRNA in vitro reveals site-selective adenosine to inosine conversion J.Biol.Chem. 270, 8566-8570 PDF
Patt, S., Thiel, G., Maas, S., Lozanova, T., Prosenc, N., Cervos-Navarro, J., Witkowski, R., and Blumenstock, M., 1993: Chromosomal changes and correspondingly altered protooncogene expression in human gliomas. Anticancer Res. 13, 113-118 Abstract